Image-guided percutaneous ablative treatments for renal cell carcinoma

被引:0
作者
Auer, Timo A. [1 ,2 ,3 ,4 ]
Uluk, Yasmin [1 ,2 ,3 ]
Grasso, Rosario Francesco [5 ]
Kloeckner, Roman [6 ]
Gebauer, Bernhard [1 ,2 ,3 ]
Kroencke, Thomas [7 ]
Collettini, Federico [1 ,4 ]
机构
[1] Charite Univ Med Berlin, Dept Radiol, Berlin, Germany
[2] Freie Univ, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany
[5] Campus Biomed Univ Rome, Dept Radiol, Rome, Italy
[6] Univ Hosp Schleswig Holstein Campus Lubeck, Inst Intervent Radiol, Lubeck, Germany
[7] Univ Hosp Augsburg, Dept Diagnost & Intervent Radiol, Augsburg, Germany
关键词
Renal cell carcinoma; Radiofrequency Ablation; Microwave ablation; Cryoablation; Partial nephrectomy; TUMOR ABLATION; PARTIAL NEPHRECTOMY; THERMAL ABLATION; KIDNEY CANCER; CRYOABLATION; OUTCOMES; MASSES;
D O I
10.1007/s00330-025-11480-w
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In recent decades, percutaneous ablation procedures have evolved into a recognized treatment option for renal cell carcinoma (RCC). Thermal ablation techniques, including radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation (CA) are now incorporated in most treatment guidelines as a viable alternative, and in some cases, deemed equivalent to nephron-sparing surgery (NSS) or other surgical methods, especially for small renal masses (SRM) up to 4 cm. This review offers an overview of the most prevalent ablation techniques used to treat localized RCC. Additionally, it compares the oncological and clinical outcomes of these techniques with those of surgical options. Finally, it provides an assessment of the role that ablation treatment occupies in current guidelines. In conclusion, the use and incorporation of image-guided minimally invasive treatment options for RCC is on the rise. Existing data suggest that thermal ablation procedures (RFA, MWA, and CA) and partial nephrectomy yield comparable oncologic and clinical outcomes. Despite the data available, the recommendations for thermal ablations vary significantly across national and international guidelines.
引用
收藏
页数:13
相关论文
共 57 条
[1]   Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel [J].
Abu-Ghanem, Yasmin ;
Fernandez-Pello, Sergio ;
Bex, Axel ;
Ljungberg, Borje ;
Albiges, Laurence ;
Dabestani, Saeed ;
Giles, Rachel H. ;
Hofmann, Fabian ;
Hora, Milan ;
Kuczyk, Markus A. ;
Kuusk, Teele ;
Marconi, Lorenzo ;
Merseburger, Axel S. ;
Tahbaz, Rana ;
Staehler, Michael ;
Volpe, Alessandro ;
Powles, Thomas ;
Lam, Thomas B. ;
Bensalah, Karim .
EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (04) :433-452
[2]   Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Technique Considerations, Safety, and Local Tumor Control [J].
Atwell, Thomas D. ;
Vlaminck, Jay J. ;
Boorjian, Stephen A. ;
Kurup, Anil N. ;
Callstrom, Matthew R. ;
Weisbrod, Adam J. ;
Lohse, Christine M. ;
Hartman, William R. ;
Stockland, Andrew H. ;
Leibovich, Bradley C. ;
Schmit, Grant D. ;
Thompson, Robert H. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 26 (06) :792-799
[3]  
Auer TA, 2024, RADIOLOGY, V310, DOI 10.1148/radiol.232044
[4]   Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review [J].
Aveta, Achille ;
Iossa, Vincenzo ;
Spena, Gianluca ;
Conforti, Paolo ;
Pagano, Giovanni ;
Dinacci, Fabrizio ;
Verze, Paolo ;
Manfredi, Celeste ;
Ferro, Matteo ;
Lasorsa, Francesco ;
Spirito, Lorenzo ;
Napolitano, Luigi ;
Tufano, Antonio ;
Fiorenza, Alessandra ;
Russo, Pierluigi ;
Crocerossa, Fabio ;
Lucarelli, Giuseppe ;
Perdona, Sisto ;
Sanseverino, Roberto ;
Siracusano, Salvatore ;
Cilio, Simone ;
Pandolfo, Savio Domenico .
LIFE-BASEL, 2024, 14 (04)
[5]   Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients [J].
Bhagavatula, Sharath K. ;
Tuncali, Kemal ;
Shyn, Paul B. ;
Levesque, Vincent M. ;
Chang, Steven L. ;
Silverman, Stuart G. .
RADIOLOGY, 2020, 296 (03) :687-695
[6]   Epidemiology of Renal Cell Carcinoma: 2022 Update [J].
Bukavina, Laura ;
Bensalah, Karim ;
Bray, Freddie ;
Carlo, Maria ;
Challacombe, Ben ;
Karam, Jose A. ;
Kassouf, Wassim ;
Mitchell, Thomas ;
Montironi, Rodolfo ;
O'Brien, Tim ;
Panebianco, Valeria ;
Scelo, Ghislaine ;
Shuch, Brian ;
van Poppel, Hein ;
Blosser, Christopher D. ;
Psutka, Sarah P. .
EUROPEAN UROLOGY, 2022, 82 (05) :529-542
[7]   Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I [J].
Campbell, Steven C. ;
Clark, Peter E. ;
Chang, Sam S. ;
Karam, Jose A. ;
Souter, Lesley ;
Uzzo, Robert G. .
JOURNAL OF UROLOGY, 2021, 206 (02) :199-208
[8]   Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies [J].
Castellana, Roberto ;
Natrella, Massimiliano ;
Fanelli, Gianluca ;
Lancellotta, Valentina ;
Cornacchione, Patrizia ;
Castellana, Marco ;
Filippiadis, Dimitrios ;
Tagliaferri, Luca ;
Iezzi, Roberto .
EUROPEAN JOURNAL OF RADIOLOGY, 2023, 165
[9]   Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma [J].
Chan, Vinson Wai-Shun ;
Osman, Filzah Hanis ;
Cartledge, Jon ;
Gregory, Walter ;
Kimuli, Michael ;
Vasudev, Naveen S. ;
Ralph, Christy ;
Jagdev, Satinder ;
Bhattarai, Selina ;
Smith, Jonathan ;
Lenton, James ;
Wah, Tze Min .
EUROPEAN RADIOLOGY, 2022, 32 (09) :5811-5820
[10]   The changing trends of image-guided biopsy of small renal masses before intervention-an analysis of European multinational prospective EuRECA registry [J].
Chan, Vinson Wai-Shun ;
Keeley, Francis Xavier, Jr. ;
Lagerveld, Brunolf ;
Breen, David J. ;
King, Alexander ;
Nielsen, Tommy Kjaergaard ;
van Strijen, Marco ;
Garnon, Julien ;
Alcorn, Des ;
Graumann, Ole ;
de Kerviler, Eric ;
Zondervan, Patricia ;
Walkden, Miles ;
Lughezzani, Giovanni ;
Wah, Tze Min .
EUROPEAN RADIOLOGY, 2022, 32 (07) :4667-4678